Market open
$
17.20
Change
+0.19 +1.12%
Volume
Volume 22,883
Feb 1, 2023, 10:00 a.m.
Real time quotes
Previous close
$ 17.01
$ 17.20
Change
+0.19 +1.12%
Day low
Day high
$16.84
$17.25

52 week low
52 week high
$6.51
$22.76

Market cap
$1.15B
Average volume
742,524
P/E ratio
N/A
Rev. per Employee
$435,321
EPS
-3.46
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on DCPH
-
Deciphera Pharmaceuticals stock price target raised to $18 from $11 at Stifel Nicolaus
- Tomi Kilgore
-
Deciphera Pharmaceuticals downgraded to hold from buy at Truist
- Tomi Kilgore
-
Deciphera Pharmaceuticals downgraded to hold from buy at Stifel Nicolaus
- Tomi Kilgore
-
Deciphera Pharmaceuticals stock price target cut to $65 from $84 at Truist
- Tomi Kilgore
-
Deciphera Pharmaceuticals coverage resumed at Stifel with buy stock rating and $60 target price
- Tonya Garcia
-
Deciphera Pharmaceuticals started at buy with $75 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
Callon, Fitbit, Genco Shipping, and Other 13D Filings
- Barron's Online
-
Deciphera Pharmaceuticals stock price target raised to $60 from $45 at SunTrust RH
- Tomi Kilgore
-
Deciphera Pharmaceuticals stock rockets 126% premarket after positive trial data for GIST treatment
- Tomi Kilgore
-
Deciphera Pharmaceuticals started at buy with $42 stock price target at Deutsche Bank
- Tomi Kilgore
-
Deciphera Pharmaceuticals started at outperform with $47 stock price target at Raymond James
- Tomi Kilgore
-
Deciphera Pharmaceuticals started at buy with $60 stock price target at SunTrust RH
- Tomi Kilgore
-
Deciphera Pharmaceuticals started at overweight with $30 stock price target at J.P. Morgan
- Tomi Kilgore
Analyst Ratings
-
Deciphera Pharma Scores A Sell-Side Recommendation
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For February 16, 2018
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For October 23, 2017
- Benzinga.com
Other News on DCPH
-
10-Q: DECIPHERA PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Deciphera Pharmaceuticals (DCPH) Presents at ESMO Congress 2022
- Seeking Alpha
-
Deciphera Pharmaceuticals Q2 2022 Earnings Preview
- Seeking Alpha
- Loading more headlines...
Press Releases on DCPH
-
Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
- BusinessWire - BZX
-
Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock
- BusinessWire - BZX
-
Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences
- BusinessWire - BZX
-
Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results
- BusinessWire - BZX
-
Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer
- BusinessWire - BZX
-
Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com